Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study

BACKGROUND: Dupilumab has shown long-term treatment benefits in children with uncontrolled asthma. We assessed in more detail the impact of dupilumab on asthma control and health-related quality of life (HRQoL) in children and their caregivers. METHODS: Children aged 6–11 years with uncontrolled mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiocchi, Alessandro G., Phipatanakul, Wanda, Zeiger, Robert S., Durrani, Sandy R., Cole, Jeremy, Msihid, Jérôme, Gall, Rebecca, Jacob-Nara, Juby A., Deniz, Yamo, Rowe, Paul J., Lederer, David J., Hardin, Megan, Zhang, Yi, Khan, Asif H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620476/
https://www.ncbi.nlm.nih.gov/pubmed/37734856
http://dx.doi.org/10.1183/13993003.00558-2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620476/
https://www.ncbi.nlm.nih.gov/pubmed/37734856
http://dx.doi.org/10.1183/13993003.00558-2023

Ejemplares similares